118 related articles for article (PubMed ID: 18266211)
1. Fractional allelic imbalance could allow for the development of an equitable transplant selection policy for patients with hepatocellular carcinoma.
Dvorchik I; Schwartz M; Fiel MI; Finkelstein SD; Marsh JW
Liver Transpl; 2008 Apr; 14(4):443-50. PubMed ID: 18266211
[TBL] [Abstract][Full Text] [Related]
2. Genotyping of hepatocellular carcinoma in liver transplant recipients adds predictive power for determining recurrence-free survival.
Marsh JW; Finkelstein SD; Demetris AJ; Swalsky PA; Sasatomi E; Bandos A; Subotin M; Dvorchik I
Liver Transpl; 2003 Jul; 9(7):664-71. PubMed ID: 12827550
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for fatal recurrence of hepatocellular carcinoma and their role in selecting candidates for liver transplantation.
Zou WL; Zang YJ; Chen XG; Shen ZY
Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):145-51. PubMed ID: 18397848
[TBL] [Abstract][Full Text] [Related]
4. Genes associated with progression and recurrence of hepatocellular carcinoma in hepatitis C patients waiting and undergoing liver transplantation: preliminary results.
Mas VR; Fisher RA; Archer KJ; Yanek KC; Williams B; Dumur CI; Maluf DG
Transplantation; 2007 Apr; 83(7):973-81. PubMed ID: 17460570
[TBL] [Abstract][Full Text] [Related]
5. Liver transplantation for hepatocellular carcinoma.
Taketomi A; Soejima Y; Yoshizumi T; Uchiyama H; Yamashita Y; Maehara Y
J Hepatobiliary Pancreat Surg; 2008; 15(2):124-30. PubMed ID: 18392704
[TBL] [Abstract][Full Text] [Related]
6. Liver transplantation in patients with hepatocellular carcinoma across Milan criteria.
Herrero JI; Sangro B; Pardo F; Quiroga J; Iñarrairaegui M; Rotellar F; Montiel C; Alegre F; Prieto J
Liver Transpl; 2008 Mar; 14(3):272-8. PubMed ID: 18306328
[TBL] [Abstract][Full Text] [Related]
7. Microdissection-based allelotyping discriminates de novo tumor from intrahepatic spread in hepatocellular carcinoma.
Finkelstein SD; Marsh W; Demetris AJ; Swalsky PA; Sasatomi E; Bonham A; Subotin M; Dvorchik I
Hepatology; 2003 Apr; 37(4):871-9. PubMed ID: 12668980
[TBL] [Abstract][Full Text] [Related]
8. Molecular signature for HCC: role in predicting outcomes after liver transplant and selection for potential adjuvant treatment.
Schmidt C; Marsh JW
Curr Opin Organ Transplant; 2010 Jun; 15(3):277-82. PubMed ID: 20414113
[TBL] [Abstract][Full Text] [Related]
9. Liver organ allocation for hepatocellular carcinoma: are we sure?
Marsh JW; Dvorchik I
Liver Transpl; 2003 Jul; 9(7):693-6. PubMed ID: 12827554
[TBL] [Abstract][Full Text] [Related]
10. Liver transplantation for hepatocellular carcinoma with intrahepatic lymphatic invasion: case reports.
Sotiropoulos GC; Molmenti EP; Fouzas I; Sgourakis G; Radtke A; Malagó M; Lang H
Transplant Proc; 2008 Nov; 40(9):3213-4. PubMed ID: 19010238
[TBL] [Abstract][Full Text] [Related]
11. Role of Allelic Imbalance in Predicting Hepatocellular Carcinoma (HCC) Recurrence Risk After Liver Transplant.
Pagano D; Barbera F; Conaldi PG; Seidita A; Di Francesco F; Di Carlo D; Bàrbara M; Tuzzolino F; Luca A; Gruttadauria S
Ann Transplant; 2019 Apr; 24():223-233. PubMed ID: 31015392
[TBL] [Abstract][Full Text] [Related]
12. [Recurrence and metastasis of hepatocellular carcinoma after liver transplantation: single center experiences].
Zheng SS; Chen J; Wang WL; Zhang M; Shen Y; Wu J; Xu X; Yan S
Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(21):1609-13. PubMed ID: 19094751
[TBL] [Abstract][Full Text] [Related]
13. Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up-to-seven criteria.
D'Amico F; Schwartz M; Vitale A; Tabrizian P; Roayaie S; Thung S; Guido M; del Rio Martin J; Schiano T; Cillo U
Liver Transpl; 2009 Oct; 15(10):1278-87. PubMed ID: 19790142
[TBL] [Abstract][Full Text] [Related]
14. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors.
Sumie S; Kuromatsu R; Okuda K; Ando E; Takata A; Fukushima N; Watanabe Y; Kojiro M; Sata M
Ann Surg Oncol; 2008 May; 15(5):1375-82. PubMed ID: 18324443
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of tumor recurrence after liver transplantation for hepatocellular carcinoma based on 1,198 cases.
Sotiropoulos GC; Molmenti EP; Lösch C; Beckebaum S; Broelsch CE; Lang H
Eur J Med Res; 2007 Oct; 12(10):527-34. PubMed ID: 18024261
[TBL] [Abstract][Full Text] [Related]
16. Predictors of survival after resection of early hepatocellular carcinoma.
Nathan H; Schulick RD; Choti MA; Pawlik TM
Ann Surg; 2009 May; 249(5):799-805. PubMed ID: 19387322
[TBL] [Abstract][Full Text] [Related]
17. Factors affecting survival and tumor recurrence in patients transplanted for hepatocellular carcinoma and coexistent hepatitis C virus.
Briceño J; Ruiz J; Ciria R; Naranjo A; Sánchez-Hidalgo J; Luque A; Rufián S; de la Mata M; López-Cillero P
Transplant Proc; 2008 Nov; 40(9):2990-3. PubMed ID: 19010170
[TBL] [Abstract][Full Text] [Related]
18. Outcome of patients with hepatocellular carcinoma listed for liver transplantation within the Eurotransplant allocation system.
Adler M; De Pauw F; Vereerstraeten P; Fancello A; Lerut J; Starkel P; Van Vlierberghe H; Troisi R; Donckier V; Detry O; Delwaide J; Michielsen P; Chapelle T; Pirenne J; Nevens F
Liver Transpl; 2008 Apr; 14(4):526-33. PubMed ID: 18383082
[TBL] [Abstract][Full Text] [Related]
19. Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence.
Vivarelli M; Cucchetti A; La Barba G; Ravaioli M; Del Gaudio M; Lauro A; Grazi GL; Pinna AD
Ann Surg; 2008 Nov; 248(5):857-62. PubMed ID: 18948815
[TBL] [Abstract][Full Text] [Related]
20. Liver transplantation for hepatocellular carcinoma: results of a multicenter study with common priorization criteria.
Santoyo J; Sanchez B; de la Mata M; Fernández-Aguilar JL; Lopez-Ciller P; Pascasio JM; Suarez MA; Gomez MA; Nogueras F; Muffak K; Cuende N; Alonso M
Transplant Proc; 2009 Apr; 41(3):1009-11. PubMed ID: 19376412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
